Dow Up0.71% Nasdaq Down0.29%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
192.70 Up 2.21(1.16%) 11:43AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 512,495   566,616   441,909   400,405  
Cost of Revenue39,626  32,939  51,552  51,358  
Gross Profit 472,869   533,677   390,357   349,047  
Operating Expenses
Research Development92,554  191,457  85,785  88,209  
Selling General and Administrative159,477  129,291  134,819  122,886  
Non Recurring1,989  3,426  31,576  2,573  
Others -   -  105  104  
Total Operating Expenses -   -  252,285  213,772  
Operating Income or Loss 218,849   209,503   138,072   135,275  
Income from Continuing Operations
Total Other Income/Expenses Net512  3,471  712  91  
Earnings Before Interest And Taxes219,361  212,974  138,784  135,366  
Interest Expense715  1,063  807  1,078  
Income Before Tax218,646  211,911  137,977  134,288  
Income Tax Expense52,151  52,557  156,969  40,503  
Minority Interest -   -   -   -  
Net Income From Continuing Ops166,495  159,354  (18,992)93,785  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 166,495   159,354   (18,992) 93,785  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 166,495   159,354   (18,992) 93,785  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.